News

All Releases
View Summary Sophiris Bio to Present at 16th Annual Needham Healthcare Conference
Mar 29, 2017
PDF 52.2 KB Add to Briefcase
View Summary Sophiris Bio Reports Fourth Quarter and Full Year 2016 Financial Results and Key Corporate Highlights
Mar 27, 2017
PDF 70.3 KB Add to Briefcase
View Summary Topsalysin Data from Successful Phase 2a Localized Prostate Cancer Study to be Presented at the 32nd European Association of Urology Congress
Mar 23, 2017
PDF 52.9 KB Add to Briefcase
View Summary Sophiris Bio to Present at 29th Annual ROTH Conference
Mar 6, 2017
PDF 52.0 KB Add to Briefcase
View Summary Sophiris Bio to Webcast Live Presentation at BetterInvesting's Virtual Investor Conference
Jan 30, 2017
PDF 29.1 KB Add to Briefcase
View Summary Sophiris Bio to Present at 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016
PDF 52.8 KB Add to Briefcase
View Summary Sophiris Bio Reports Third Quarter 2016 Financial Results and Key Business Highlights
Nov 9, 2016
PDF 28.4 KB Add to Briefcase
View Summary Sophiris Bio to Present at the 2016 BIO Investor Forum
Oct 10, 2016
PDF 13.6 KB Add to Briefcase
View Summary Sophiris Bio Closes Underwritten Public Offering
Aug 26, 2016
PDF 17.4 KB Add to Briefcase
View Summary Sophiris Bio Prices Public Offering of Common Shares and Warrants
Aug 23, 2016
PDF 17.1 KB Add to Briefcase
View Summary Sophiris Bio Announces Proposed Public Offering of Common Shares and Warrants
Aug 22, 2016
PDF 16.7 KB Add to Briefcase
View Summary Sophiris Bio Reports Second Quarter 2016 Financial Results and Key Business Highlights
Aug 9, 2016
PDF 29.3 KB Add to Briefcase
View Summary Sophiris Bio Reports Successful Results from Completed Phase 2a Study of Topsalysin in Localized Prostate Cancer
Jun 9, 2016
PDF 21.2 KB Add to Briefcase
View Summary Sophiris Bio Reports First Quarter 2016 Financial Results and Key Business Highlights
May 16, 2016
PDF 26.9 KB Add to Briefcase
View Summary Sophiris Bio Engages Oppenheimer & Co. to Advise on Strategic Opportunities
May 12, 2016
PDF 15.2 KB Add to Briefcase
View Summary Sophiris Bio Inc. Announces Closing of Public Offering of $5,000,000
May 11, 2016
PDF 15.1 KB Add to Briefcase
View Summary Sophiris Bio Inc. to Raise Approximately $5 Million Through At-the-Market Offering
May 6, 2016
PDF 15.8 KB Add to Briefcase
View Summary Sophiris Bio To Present Topsalysin Phase 3 Data from Positive PLUS-1 Study as a Late Breaking Poster During the 111th American Urological Association Annual Meeting
May 5, 2016
PDF 14.5 KB Add to Briefcase
View Summary Sophiris Bio to Present at Bloom Burton & Co. Healthcare Investor Conference
Apr 28, 2016
PDF 13.7 KB Add to Briefcase
View Summary Sophiris Bio Reports Fourth Quarter and Full Year 2015 Financial Results and Key Business Highlights
Mar 23, 2016
PDF 30.0 KB Add to Briefcase
Showing 1-20 of 66 Page: 1 2 3 4  Next 20
Add to Briefcase = add release to Briefcase